Banghulot, Raymie H.
HRN: 25-78-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/29/2024
08/30/2024
IVT
4g
Q6 X 24 Hours
S/P Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes